RT Journal Article
SR Electronic
T1 Serial Interval Distribution of SARS-CoV-2 Infection in Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.09.20127043
DO 10.1101/2020.06.09.20127043
A1 Carlos A. Prete, Jr
A1 Lewis Buss
A1 Amy Dighe
A1 Victor Bertollo Porto
A1 Darlan da Silva Candido
A1 Fábio Ghilardi
A1 Oliver G. Pybus
A1 Wanderson K. de Oliveira
A1 Júlio H. R. Croda
A1 Ester C. Sabino
A1 Nuno Rodrigues Faria
A1 Christl A. Donnelly
A1 Vítor H. Nascimento
YR 2020
UL http://medrxiv.org/content/early/2020/06/22/2020.06.09.20127043.abstract
AB Using 65 transmission pairs of SARS-CoV-2 reported to the Brazilian Ministry of Health we estimate the mean and standard deviation for the serial interval to be 2.97 and 3.29 days respectively. We also present a model for the serial interval probability distribution using only two parameters.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a Medical Research Council (MR/S0195/1) and FAPESP (2018/14389-0) CADDE partnership award and a John Fell Research Fund (grant 005166). NRF is supported by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship (204311/Z/16/Z). DDSC is supported by the Clarendon Fund and by the Oxford University Zoology Department. CAPJ and VHN are supported in part by FAPESP grant 2018/12579-7. CAD is thankful for Centre funding from the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union (MR/R015600/1). AD is also supported by the UK Medical Research Council (MRC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval: CONEP protocol number 30127020.0.0000.0068.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for this analysis were provided by the Brazilian Ministry of Health.